Article (Scientific journals)
The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides.
Meyrath, Max; Szpakowska, Martyna; Zeiner, Julian et al.
2020In Nature Communications, 11 (1), p. 3033
Peer Reviewed verified by ORBi
 

Files


Full Text
The_atypical_2020.pdf
Publisher postprint (1.86 MB)
Download

OA


All documents in ORBilu are protected by a user license.

Send to



Details



Keywords :
opioid peptides; ACKR3; Chemokine Receptor
Abstract :
[en] Endogenous opioid peptides and prescription opioid drugs modulate pain, anxiety and stress by activating opioid receptors, currently classified into four subtypes. Here we demonstrate that ACKR3/CXCR7, hitherto known as an atypical scavenger receptor for chemokines, is a broad-spectrum scavenger of opioid peptides. Phylogenetically, ACKR3 is intermediate between chemokine and opioid receptors and is present in various brain regions together with classical opioid receptors. Functionally, ACKR3 is a scavenger receptor for a wide variety of opioid peptides, especially enkephalins and dynorphins, reducing their availability for the classical opioid receptors. ACKR3 is not modulated by prescription opioids, but we show that an ACKR3-selective subnanomolar competitor peptide, LIH383, can restrain ACKR3's negative regulatory function on opioid peptides in rat brain and potentiate their activity towards classical receptors, which may open alternative therapeutic avenues for opioid-related disorders. Altogether, our results reveal that ACKR3 is an atypical opioid receptor with cross-family ligand selectivity.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Meyrath, Max;  Luxembourg Institute of Health (LIH), Luxembourg.
Szpakowska, Martyna;  Luxembourg Institute of Health (LIH), Luxembourg.
Zeiner, Julian;  Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn
Massotte, Laurent;  Neurophysiology Unit, GIGA Neurosciences, University of Liège
Merz, Myriam P.;  Luxembourg Institute of Health (LIH), Luxembourg.
Benkel, Tobias;  Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn
Simon, Katharina;  Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn
Ohnmacht, Jochen ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
Turner, Jonathan ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) ; Luxembourg Institute of Health (LIH), Luxembourg.
Krüger, Rejko ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit
Seutin, Vincent;  Neurophysiology Unit, GIGA Neurosciences, University of Liège
Ollert, Markus;  Luxembourg Institute of Health (LIH), Luxembourg.
Kostenis, Evi;  Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn
Chevigné, Andy ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) ; Luxembourg Institute of Health (LIH), Luxembourg.
More authors (4 more) Less
External co-authors :
yes
Language :
English
Title :
The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides.
Publication date :
2020
Journal title :
Nature Communications
ISSN :
2041-1723
Publisher :
Nature Publishing Group, London, United Kingdom
Volume :
11
Issue :
1
Pages :
3033
Peer reviewed :
Peer Reviewed verified by ORBi
Focus Area :
Systems Biomedicine
FnR Project :
FNR6682797 - Comprehensive Assessment Of Endophenotypes In Neurodegenerative Diseases - Translating Impaired Molecular Signalling Pathways Into Novel Therapeutic Strategies For Parkinson'S Disease, 2013 (01/06/2014-31/05/2019) - Rejko Krüger
Available on ORBilu :
since 30 June 2020

Statistics


Number of views
133 (4 by Unilu)
Number of downloads
59 (2 by Unilu)

Scopus citations®
 
63
Scopus citations®
without self-citations
46
OpenCitations
 
53
WoS citations
 
61

Bibliography


Similar publications



Contact ORBilu